HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1486
https://www.valueinhealthjournal.com/article/S1098-3015(22)03691-9/fulltext
Section Title :
Section Order :
11037
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03691-9&doi=10.1016/j.jval.2022.09.1486